14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AIMT
Delisted

Aimmune Therapeutics Stock Price (Quote)

$34.49
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $5.34 $19.02 Friday, 27th May 2022 AIMT stock ended at $34.49. During the day the stock fluctuated 0% from a day low at $34.49 to a day high of $34.49.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Aimmune Therapeutics prices

Date Open High Low Close Volume
Dec 04, 2019 $28.77 $29.50 $28.61 $29.40 699 485
Dec 03, 2019 $27.69 $28.71 $27.64 $28.59 586 207
Dec 02, 2019 $28.01 $28.10 $27.35 $27.89 796 550
Nov 29, 2019 $27.98 $28.14 $27.82 $27.92 286 233
Nov 27, 2019 $27.42 $28.22 $27.38 $27.99 572 666
Nov 26, 2019 $27.75 $28.00 $27.26 $27.37 387 149
Nov 25, 2019 $27.75 $28.05 $26.98 $27.81 790 297
Nov 22, 2019 $26.74 $27.55 $26.35 $27.51 501 584
Nov 21, 2019 $25.81 $26.62 $25.26 $26.48 1 066 900
Nov 20, 2019 $27.23 $27.25 $25.65 $25.77 1 673 879
Nov 19, 2019 $27.07 $27.70 $27.00 $27.40 857 568
Nov 18, 2019 $27.06 $27.23 $26.38 $26.95 557 411
Nov 15, 2019 $27.09 $27.09 $26.46 $26.67 568 517
Nov 14, 2019 $27.42 $27.68 $26.64 $26.83 602 497
Nov 13, 2019 $28.24 $28.24 $27.20 $27.57 870 387
Nov 12, 2019 $28.73 $29.28 $28.17 $28.32 456 707
Nov 11, 2019 $28.98 $29.50 $28.52 $28.82 497 613
Nov 08, 2019 $28.50 $29.68 $28.34 $29.48 626 668
Nov 07, 2019 $28.13 $29.38 $25.77 $28.37 903 893
Nov 06, 2019 $29.08 $29.37 $28.46 $28.59 492 915
Nov 05, 2019 $29.14 $29.62 $28.88 $29.01 595 014
Nov 04, 2019 $29.20 $29.25 $28.63 $29.11 546 824
Nov 01, 2019 $28.05 $28.94 $27.60 $28.91 674 224
Oct 31, 2019 $27.28 $27.86 $26.83 $27.82 515 304
Oct 30, 2019 $27.52 $27.82 $27.06 $27.49 548 554
Click to get the best stock tips daily for free!

About Aimmune Therapeutics

Aimmune Therapeutics Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. Its Characterized Oral Desensitization Immunotherapy includes AR101, a product in Phase 3 registration trial for the treatment of peanut allergy in children and adults. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. ... AIMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT